program friday - Munich Vascular Conference

MVC 

incooperating 

the 2 nd Munich Aortic Conference (MAC) and the 2 nd Munich Carotid Conference (MCC) 

VENUE 

MUNICH VASCULAR 

CONFERENCE 

2012 where doctors meet science 

www.munich-vascular-conference.com 

Klinikum rechts der Isar, Munich, Germany 

November 30 th and 

December 1 st , 2012 

CHAIRMEN (Technische Universität München, TUM) 

Hans-Henning Eckstein 

Klinikum rechts der Isar, Department for Vascular and Endovascular Surgery 

Rüdiger Lange 

Deutsches Herzzentrum München, Department for Cardiovascular Surgery 

Markus Schwaiger 

Klinikum rechts der Isar, Department for Nuclear Medicine 

Holger Poppert 

Klinikum rechts der Isar, Department for Neurology

Endovascular Competence. 

Thoracic Aorta 

Valiant® Captivia 

Stent Graft 

Abdominal Aorta 

Endurant® 

Stent Graft 

Femoral 

Maris Plus 

Stent 

Admiral Xtreme 

Balloon 

IN.PACT Admiral 

Drug-Eluting Balloon 

Universal 

Pioneer Plus 

Re-Entry Catheter 

Reef 

High Pressure Balloon 

Reliant® 

Stent Graft Balloon 

Carotid 

Cristallo Ideale 

Stent 

Submarine Rapido 

Balloon 

Piton GC 

Guiding Catheter 

MO.MA Ultra / Fibernet 

Protection Device 

Kidney 

Hippocampus / Racer RX 

Stents 

Iliac 

Scuba / Assurant Cobalt / 

Complete SE / Maris Plus 

Stents 

Admiral Xtreme 

Balloon 

Knee 

Pacifi c Xtreme 

Balloon 

IN.PACT Pacifi c 


Below the knee 

Maris Deep / Chromis Deep 

Stents 

Amphirion Deep 

Balloon 

KiteWire Deep 

Guidewire 

IN.PACT Amphirion 


Innovating for life.

TABLE OF CONTENTS where doctors meet science 

Welcome ................................................................................. 4 

Program at a Glance ................................................................. 6 

Scientific Program 

Friday, November 30 th ............................................................... 8 

Scientific Program 

Saturday, December 1 st ............................................................ 13 

Faculty .................................................................................. 18 

Keynote and Special Lectures ................................................. 24 

Symposia and Workshops ...................................................... 26 

General Information .............................................................. 28 

Sponsors and Exhibitors ......................................................... 30 

Directions ............................................................................. 32 

www.munich-vascular-conference.com

where doctors meet science 

Hans-Henning Eckstein 

Klinikum rechts der Isar 

der Technischen Universität München 

Department for Vascular and Endovascular Surgery 

Rüdiger Lange 

Deutsches Herzzentrum 


Department for Cardiovascular Surgery 

Markus Schwaiger 



Department for Nuclear Medicine 

Holger Poppert 



Department for Neurology 

WELCOME 

Dear colleagues, 

after a very positive response to the 1 st Munich 

Aortic Conference (MAC) and the 1 st Munich 

Carotid Conference (MCC) in November and 

December 2011, it is a pleasure to invite you to 

the Munich Vascular Conference (MVC) 2012. 

Aortic and carotid diseases constitute different 

entities, however, share a variety of commonalities. 

For example, an unstable aortic wall 

in a patient with an aortic aneurysm may lead 

to an aortic rupture, whereas an unstable carotid 

plaque may embolise and cause an ischemic 

stroke. In addition, both blood vessel 

disorders affect in particular elderly patients, 

where the risk of any intervention (either 

open or endovascular) has to be balanced 

against the natural course of the disease. 

Even though a great variety of different imaging 

and treatment modalities are available, 

we still make use of rather old-fashioned criteria, 

such as the degree of stenosis or the maximum 

aortic diameter, to recommend either 

open or endovascular intervention. In many 

cases this leads to uncertainty whether or not 

the individual patient should be treated by 

conservative, endovascular or traditional open 

surgical means. In addition, it is quite clear 

that so-called “benign lesions” like non-stenotic 

carotid plaques and small aneurysms may 

become symptomatic or even cause strokes 

and ruptures. Consequently, there is a need for 

better criteria to identify patients at risk and 

to refrain from unnecessary interventions. 

4

The Munich Vascular Conference (MVC) 2012 

therefore aims to establish an academic platform 

for clinical researchers from vascular/cardiovascular 

surgery and neurology, radiologists and imaging 

specialists, vascular biologists, technicians and 

otherwise involved specialists from cardiology, 

anesthesia and other fields. A highly qualified 

international faculty will report about their latest 

clinical and basic research on conventional and 

functional imaging, simulation and open or endovascular 

treatment modalities for the entire aorta 

and the extracranial carotid bifurcation. 

MVC 2012 will thereby be a combination of the 2 nd 

Munich Aortic Conference and the 2 nd Munich 

Carotid Conference. 

The Munich Vascular Conference 2012 will be held 

under the patronage of the German Vascular 

Society (DGG) and the foundation VASCULAR 

INTERNATIONAL. We look forward to welcoming 

you in Munich. 

Hans-Henning Eckstein Rüdiger Lange 

Markus Schwaiger Holger Poppert 

WELCOME where doctors meet science 

5


PROGRAM AT A GLANCE 

MCC (2 nd Munich Carotid Conference) MAC (2 nd Munich Aortic Conference) 

FRIDAY, NOVEMBER 30 th 

09:00– 

10:30 

10:30– 

11:00 

11:00– 

12:30 

11:00– 

13:00 

12:35– 

13:00 

13:00– 

13:30 

13:30– 

14:20 

13:30– 

15:30 

14:30– 

16:00 

16:00– 

16:45 

16:00– 

16:30 

16:30– 

18:00 

MCC 1: Novel concepts to 

treat carotid related strokes 

coffee break 

MCC 2: Current management 

of supra-aortic vasculitis, carotid 

dissection and post-radiotherapy 

stenosis 

09:00- 

10:30 

11:00- 

12:30 

MAC 1: Genetics and 

proteomics in aortic disease 

MAC 2: Epidemiology, 

screening and medical 

intervention for aortic 

aneurysms 

SIMULATOR TRAINING FOR ENDOVASCULAR INTERVENTIONS - CORDIS 

SPECIAL LECTURE: What besides patient benefit motivates vascular 

surgeons and vascular specialists? 

lunch break 

LUNCHSESSION I 

MEDTRONIC 

Optimized therapy 

of ruptured AAA 

13:30– 

14:20 

LUNCHSESSION II 

VASCUTEK 

Latest techniques in the 

treatment of aortic diseases 

SIMULATOR TRAINING FOR ENDOVASCULAR INTERVENTIONS - CORDIS 

MCC 3: Vulnerable carotid 

plaques – new findings from 

the laboratory 

WORKSHOP BOSTON SCIENTIFIC 

Carotid Stenting 

coffee break 

MCC 4: Ultrasound techniques 

to assess carotid plaques 

beyond the degree of stenosis 

14:30– 

16:00 

16:30– 

18:00 

MAC 3: Acute aortic 

dissection (type A and B) – 

TEVAR unlimited? 

MAC 4: Functional imaging 

and computational fluid 

dynamics – any news in risk 

prediction? 

19:00 Get-Together with live music from the “Freddy Wonder Combo“ 

(8seasons Munich, Sonnenstrasse 26, 80331 Munich) 

6

PROGRAM AT A GLANCE where doctors meet science 


SATURDAY, DECEMBER 1 st 

09:00– 

10:30 

10:30– 

11:00 

11:00– 

12:30 

12:35– 

13:00 

13:00– 

13:30 

13:30– 

14:20 

14:30– 

16:00 

MCC 5: Ongoing carotid 

trials – rationale, design 

and current status 

coffee break 

09:00– 

10:30 

MCC 6: The future of CAS 11:00– 

12:30 

MAC 5: Treatment options 

for the aortic arch – hybrid 

or hybris? 

MAC 6: TAAA - how to stratify 

patients for open surgery or 

TEVAR – the need for a 

consensus 

SPECIAL LECTURE: Is there a need to centralize the vascular provision in 

dedicated high-volume centers? 

lunch break 

LUNCHSESSION III 

PHILIPS 

Hybrid-OR – State of the art 

imaging in vascular surgery 

MCC 7: Molecular imaging of 

atherosclerotic carotid lesions 

13:30– 

14:20 

14:30– 

16:00 

16:00 end of scientific program 

7 

LUNCHSESSION IV 

W. L. GORE 

Clinical data and practical 

challenges in EVAR and TEVAR 

MAC 7: Abdominal aortic 

aneurysms: advances and 

limitations in EVAR


PROGRAM FRIDAY 


09:00 – 

10:30 

10:30 – 

11:00 

MCC 1 

Novel concepts to treat 

carotid related strokes 

Chair: 

B. Hemmer, Munich, Germany 

C. Zimmer, Munich, Germany 

Clinical severity and outcome 

of carotid related strokes 

P. Ringleb, Heidelberg, Germany 

State of the art imaging for 

acute stroke therapy 

A. Dörfler, Erlangen, Germany 

Endovascular recanalization of 

acute occlusions of the internal 

carotid artery 

T. Liebig, Cologne, Germany 

Mechanical recanalization of 

intracranial arteries – techniques 

and outcome 

A. Förschler, Munich, Germany 

Open surgery for acute carotid 

strokes – still an option? 

L. Deutsch, Munich, Germany 

H.-H. Eckstein, Munich, Germany 

Endarterectomy has to be performed 

urgently after a carotid 

related cerebral ischemia 

NN 

Summary of Chairmen 

coffee break 

8 

09:00 – 

10:30 

MAC 1 

Genetics and proteomics in 

aortic diseases 

Chair: 

G. Pasterkamp, Utrecht, The Netherlands 

J. Pelisek, Munich, Germany 

Gene expression and genetic 

association studies in AAA 

I. Hinterseher, Berlin, Germany 

The impact of chronic inflammation 

on progression and 

destabilization of AAA 

J. Lindeman, Leiden, The Netherlands 

Marfan Syndrome: implications 

of new molecular concepts in 

thoracic aortic diseases 

J. Schmidli, Bern, Switzerland 

Biomarkers – do they reflect 

proteolysis and degradation 

in AAA? 


Who should be screened for 

a gene-associated aortic 

disease? 

Y. von Kodolitsch, Hamburg, Germany 

Summary of Chairmen

PROGRAM FRIDAY where doctors meet science 


11:00 – 

12:30 

MCC 2 

Current management of supraaortic 

vasculitis, carotid dissection 

and post-radiotherapy stenosis 

Chair: 

H. Poppert, Munich, Germany 


KEYNOTE LECTURE: 

Vasculitis of the extra- and 

intracranial arteries – etiology, 

stroke risk and treatments 

P. Berlit, Essen, Germany 

Vessel wall inflammation in 

spontaneous cervical artery 

dissection assessed by PET-CT 

and MRI 

T. Pfefferkorn, Munich, Germany 

Long-term results of stent 

grafting of ICA dissections 

and FMD 

A. Assadian, Vienna, Austria 

Sudden retinal blindness: 

Arteritis or embolic occlusion? 

The sonographic spot sign 

F. Schlachetzki, Regensburg, Germany 

Outcomes following CAS or 

CEA in post-radiotherapy 

carotid stenosis 

A. H. Davies, London, UK 

11:00 – 

12:30 

MAC 2 

Epidemiology, screening and 

medical intervention for 

aortic aneurysms 

Chair: 

M. Halle, Munich, Germany 

J.-B. Ricco, Poitiers, France 


Triumphs and tribulations in 

a national AAA screening 

program 

J. Earnshaw, Gloucestershire, UK 

How to implement a national 

AAA screening program in 

Portugal 

A. Mansilha, Porto, Portugal 

Pharmaceutical stabilization of 

AAAs – are there any advances 

and how effective is doxycycline 

in a contemporary RCT? 

J. Lindeman, Leiden, The Netherlands 

Descending thoracic aortic 

aneurysms – a new epidemic? 

J. Powell, London, UK 

Ultrasound screening for AAA 

in COPD patients – is it 

worthwhile? 

I. Flessenkämper, Berlin, Germany 

Summary of Chairmen Is there a need for a screening 

program for ascending 

aortic aneurysms? 

U. Herold, Munich, Germany 

9 

Summary of Chairmen




12:35– 

13:00 

13:00 – 

13:30 

13:30 – 

14:20 

14:30 – 

16:00 

SPECIAL LECTURE 

What besides patient benefit motivates vascular surgeons and vascular 

specialists? 

F. J. Veith, New York, USA 

lunch break 

LUNCHSESSION I – MEDTRONIC 

Optimized therapy 

of ruptured AAA 

Chair: 

T. A. Koeppel, Munich, Germany 

H. Schelzig, Dusseldorf, Germany 

Management of the ruptured 

patient 


Technical aspects of EVAR 

for rAAA 

T. Umscheid, Bad Nauheim, Germany 

Optimized treatment 

of rAAA patients 


MCC 3 

Vulnerable carotid plaques – 

new findings from the 

laboratory 

Chair: 


A. Zernecke, Munich, Germany 

KEYNOTE LECTURE 

Similarity and differences 

between carotid, aortic and 

coronary atherosclerosis 

R. Virmani, Gaithersburg, USA 

10 

13:30 – 

14:20 

14:30 – 

16:00 

LUNCHSESSION II – VASCUTEK 

Latest techniques in the 

treatment of aortic diseases 

Chair: 

J. Kalder, Aachen, Germany 

M. L. Shrestha, Hanover, Germany 

Engineering and functional 

considerations of a ring stent 

design 

D. Stevenson, Renfrewshire, UK 

Fenestrated Anaconda – 

the range of possibilities 


Thoraflex Hybrid – 

new approach for thoracic 

aortic diseases 


MAC 3 

Acute aortic dissection 

(type A and B) – TEVAR 

unlimited? 

Chair: 


B. Voss, Munich, Germany 

KEYNOTE LECTURE 

Surgical standards in aortic 

dissection type A 

R. Lange, Munich, Germany

PROGRAM FRIDAY where doctors meet science 


16:00– 

16:45 

16:00– 

16:30 

Vulnerable plaques: Basic 

pathology, animal models 

and clinical correlates 

S. Ylä-Herttuala, Kuopio, Finland 

Hypoxia and classical macrophage 

activation as targets 

for plaque stabilization 

A. Newby, Bristol, UK 

Novel mechanisms for atheroprotection 

in the carotid 

artery 

C. Weber, Munich, Germany 


WORKSHOP BOSTON SCIENTIFIC 


H. Berger, Munich, Germany 

coffee break 

11 

Extent of arch repair and the 

impact of age in aortic 

dissection type A – data from 

GERAADA 

M. Czerny, Bern, Switzerland 

Transapical access for endovascular 

treatment in acute 

type A dissection 

T. Kölbel, Hamburg, Germany 

Contemporary series of uncomplicated 

aortic dissection 

type B treated conservatively 

A. Greiner, Aachen, Germany 

Which uncomplicated acute 

type B dissection can benefit 

from TEVAR? 

V. Riambau, Barcelona, Spain 

Endovascular treatment for 

acute complicated aortic 

dissection 

P. Taylor, London, UK 

5-year results from the 

INSTEAD trial 

C. Nienaber, Rostock, Germany 

Summary of Chairmen




16:30 – 

18:00 

19:00 

MCC 4 

Ultrasound techniques to 

assess carotid plaques beyond 

the degree of stenosis 

Chair: 

E. Bartels, Munich, Germany 

K. Stock, Munich, Germany 

Intima-media-thickness – what 

does it mean for the individual 

patient? 

D. Sander, Tutzing, Germany 

Plaque texture and plaque 

inflammation assessed by 

ultrasound – is it the answer? 

A. H. Davies, London, UK 

Duplex contrast-enhanced 

ultrasound of carotid plaques 

E. Vicenzini, Rome, Italy 

Carotid plaque morphology 

and embolic potential 

C. Liapis, Athens, Greece 

Does emboli detection add 

anything to detect vulnerable 

carotid plaques? 

M. Siebler, Essen, Germany 


16:30 – 

18:00 

MAC 4 

Functional imaging and 

computational fluid dynamics – 

any news in risk prediction? 

Chair: 

A. Maier, Munich, Germany 

W. Wall, Munich, Germany 

Biomechanical assessment of 

the rupture risk of AAA 

C. Gasser, Stockholm, Sweden 

Does FDG PET-CT correlate 

with Finite Element analyses 

and may this help to predict 

the rupture risk in AAA? 

C. Reeps, Munich, Germany 

Degree of calcification as a 

prognostic factor for rupture 

risk of the abdominal aortic 

aneurysm 

C. Zeebregts, Groningen, 

The Netherlands 

4D MR imaging for risk stratification 

in aortic dissection 

R. Clough, London, UK 

Increased confidence in AAA 

assessment through 

computations 

M. Gee, Munich, Germany 


Get-Together with live music from the „Freddy Wonder Combo“ 

(8seasons Munich, Sonnenstrasse 26, 80331 Munich) 

12

PROGRAM SATURDAY where doctors meet science 


09:00 – 

10:30 

MCC 5 

Ongoing carotid trials – rationale, 

design and current status 

Chair: 


H. Sillesen, Copenhagen, Denmark 

What is necessary to bring 

SPACE-2 to a success? 


ACST-2: the first results! 

A. Halliday, Oxford, UK 

ECST-2: do carotid patients with 

a low or intermediate stroke risk 

really benefit from CEA (or CAS)? 

M. Brown, London, UK 

CREST: the ongoing debate 

about CREST-1 and how does 

that impact CREST-2? 


CABACS: combining carotid and 

cardiac surgery – is that safe? 

C. Weimar, Essen, Germany 

Impact of different CAS techniques 

on outcomes in three 

European RCTs (CSTC, Carotid 

Stenting Trialists Collaboration) 

F. Wodarg; O. Jansen, Kiel, Germany 

Impact of different CEA techniques 

on outcomes in three 

European RCTs (CSTC, Carotid 

Stenting Trialists Collaboration) 



13 

09:00 – 

10:30 

MAC 5 

Treatment options for the 

aortic arch – hybrid or hybris? 

Chair: 

R. Lange, Munich, Germany 

H. J. Safi, Houston, USA 

Open treatment for the aortic 

arch: the retrograde technique 


Open surgery for aortic arch replacement 

surgery versus TEVAR 

A. Khoynezhad, Los Angeles, USA 

Anaesthetic considerations in 

open arch repair 

P. Tassani-Prell, Munich, Germany 

Arch repair with branched endografts 

and first experiences 

on TEVAR for ascending aortic 

aneurysms 

S. Haulon, Lille, France 

How to improve the endograft 

conformability in the aortic arch 

V. Riambau, Barcelona, Spain 

TEVAR for arch aneurysms – 

challenges, planning and 

techniques for good outcomes 

T. Kölbel, Hamburg, Germany 

Summary of Chairmen


PROGRAM SATURDAY 


10:30 – 

11:00 

11:00 – 

12:30 

coffee break 

MCC 6 

The future of CAS 

Chair: 

M. Brown, London, UK 


Asymptomatic carotid stenosis: 

red light for CAS (and CEA)? 

J.-B. Ricco, Poitiers, France 

Proper training is the key for 

successful CAS 

S. Macdonald, Newcastle, UK 

Why do I use OCT during CAS? 

C. Setacci, Siena, Italy 

Velocity distribution in stents 

and filters in the carotid bifurcation 

assessed by Laser- 

Doppler-Anemometry (LDA) 

D. Liepsch, Munich, Germany 

Intraindividual results of CAS 

and CEA – is it the patient rather 

than the technology that 

predicts good or bad results? 

G. Torsello, Munster, Germany 

14 

11:00 – 

12:30 

MAC 6 

TAAA – how to stratify patients 

for open surgery or TEVAR – 

the need for a consensus 

Chair: 


M. Thompson, London, UK 


Open surgery remains to be 

the golden standard for TAAA 

in surgically fit patients 

H. J. Safi, Houston, USA 

The role of neuromonitoring 

in open and endovascular 

TAAA repair: academic approach 

or clinically important? 

M. Jacobs, Aachen, Germany / 

Maastricht, The Netherlands 

Multimodal prophylaxis of 

spinal ischemia during branched 

and fenestrated TEVAR 

P. Kasprzak, Regensburg, Germany 

Mid- and long-term results 

after hybrid repairs for TAAAs 

J. Wolfe, London, UK 

Predictors of outcome following 

TEVAR for chronic dissection 

P. Taylor, London, UK



12:35– 

13:00 

13:00– 

13:30 

13:30 – 

14:20 

Technologies and techniques 

to avoid macro- and microembolism 

during CAS 

D. Scheinert, Leipzig, Germany 

Endovascular repair of TAAA – 

is it durable? 

S. Haulon, Lille, France 

Summary of Chairmen Summary of Chairmen 

SPECIAL LECTURE 

Is there a need to centralize the vascular provision in dedicated highvolume 

centers? 


lunch break 

LUNCHSESSION III – PHILIPS 



Hybrid-OR – Clinical experience 




J. Güra, Hamburg, Germany 

15 

13:30 – 

14:20 

LUNCHSESSION IV – W. L. GORE 

Clinical data and practical 

challenges in EVAR and TEVAR 

Chair: 


Sharing experience: EVAR in 

more than 100 patients with 

the GORE®EXCLUDER® AAA 

Endoprosthesis 

R. Ghotbi, Munich, Germany 

Treatment of acute uncomplicated 

type B aortic dissection: 

1 year results from the 

ADSORB study 

P. Taylor, London, UK


PROGRAM SATURDAY 


14:30 – 

16:00 

MCC 7 

Molecular imaging of atherosclerotic 

carotid lesions 

Chair: 

M. Schwaiger, Munich, Germany 

A. Zernecke, Munich, Germany 

Advances in biological 

characterization of atherosclerosis 

by MRI 

R. Botnar, London, UK 

X-ray based phase contrast 

imaging: a new imaging 

method to identify the 

vulnerable plaque? 

T. Saam, Munich, Germany 

Quantification of inflammation 

with 18F FDG PET and 

neovascularization with DCE 

MRI in carotid plaques 

E. Kooi, Maastricht, The Netherlands 

Ongoing results with clinical 

PET studies to detect carotid 

vulnerability 

C. Zeebregts, Groningen, 


Molecular imaging of the vascular 

wall by use of PET-MRI 

I. Laitinen, Munich, Germany 


16 

14:30 – 

16:00 

MAC 7 

Abdominal aortic aneurysms: 

advances and limitations in 

EVAR 

Chair: 


G. Torsello, Munster, Germany 

Do all patients need surveillance 

after EVAR for AAA and 

which diagnostics are 

reasonable? 


Volume estimation of the aortic 

sac after EVAR using 3D 

ultrasound – a novel, accurate 

and promising technique 

H. Sillesen, Copenhagen, Denmark 

Quality of life after open repair 

or EVAR – long-term results 

from the Dutch DREAM trial 

J. Blankensteijn, Amsterdam, 


Stapling of the infrarenal EVAR 

body to treat or prevent type I 

endoleaks – does it work? 

J.-P. de Vries, Nieuwegein, 


Long-term results after EVAR 

combined with iliac branches 

F. Verzini, Perugia, Italy 

CT-angiography at 24 months 

proves durability of EVAR with 

use of chimney and periscope 

grafts for pararenal AAAs 

K. Donas, Munster, Germany



16:00 end of scientific program 

THE NEW, NEW 

, MORE NATURAL NAT TU APPROACH 

TO 

OPTIMAL OP TIMAL FIT 

Conformability without Compromise 

Pr Pre-Intervention e-Intervention 

Post-Intervention 

PERFORMANCE by design 

The new Conformable GORE ® TAG ® ® ® 

The new Conformable 

e GORE TAG 

Thoracic 


off offers ers 

a unique u ni nique 

6–33% oversizing oversizing 

wwindow: 

indow: 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

��GORE ® , C3, EXCLUDER ® ��, TAG ® �� 

® 

® 

® 

��GORE 

, C3, EXCLUDER 

�� 

��, 

TA AG �� 

�� 

� � � � � � � � � � � � � � � � � � 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

GORE ® GORE Tri-Lobe Tri-L 

o obe 

Balloon 

Catheter C athet atheter 

GORE ® EXCLUDER ® ® 

® 

GORE EXCLUDER 


Endopr o osthesis 

ffeaturing 

eaturing 

C3 Delivery 

System Syst 

em 

GORE ® GORE 

DrySeal 

She Sheath ath 

When and how to use Palmaz 

stents to treat or prevent 

type 1 endoleaks 

A. Zimmermann, Munich, Germany 


® ® 

Introducin 

g the New Standard 

in Conformability 

and Radi 

al Fit. 

The Conformable 

GORE TAG 

Thor 

acic 

Endoprosthesis. 

17 

Learn 

more 

about confoormability 

and 

ra radial 

fit 

at 

www www.conformabletag.com 

. confoormabletag. 

com


FACULTY 

CHAIRMEN 

(Technische Universität München, TUM | Munich | Germany) 

�� Hans-Henning Eckstein (Coordinator) 

Department for Vascular and Endovascular Surgery | Klinikum rechts der Isar 

� Rüdiger Lange 

Department for Cardiovascular Surgery | Deutsches Herzzentrum München 

� Markus Schwaiger 

Department for Nuclear Medicine | Klinikum rechts der Isar 

� Holger Poppert 

Department for Neurology | Klinikum rechts der Isar 

LOCAL COORDINATING COMMITTEE 

(Technische Universität München, TUM | Munich | Germany) 

� Michael Gee 

Institute for Computational Mechanics | Garching/Munich 

� Ulf Herold 


� Jaroslav Pelisek 

Department for Vascular and Endovascular Surgery | Section for Vascular Biology | 


� Christian Reeps 


� Bernhard Voss 


� Alma Zernecke 

Department for Vascular and Endovascular Surgery | Section for Vascular Biology | 


� Claus Zimmer 

Department for Neuroradiology | Klinikum rechts der Isar 

� Alexander Zimmermann 


18

SCIENTIFIC FACULTY 

FACULTY where doctors meet science 

�� Afshin Assadian 

Department for Vascular and Endovascular Surgery I Wilhelminenspital I Vienna I Austria 

� Eva Bartels 

Department for Neurology I Klinikum rechts der Isar der Technischen Universität München I Munich I Germany 

� Hermann Berger 

Interventional Radiology | Klinikum rechts der Isar der Technischen Universität München I Munich | Germany 

� Peter Berlit 

Department for Neurology I Alfried Krupp Krankenhaus I Essen I Germany 

� Jan Blankensteijn 

Division of Vascular Surgery I VU Medical Center I Amsterdam I The Netherlands 

� Rene Botnar 

Department for Imaging Sciences and Biomedical Engineering I King's College London I London I 

United Kingdom 

� Martin Brown 

Institute of Neurology I University College London I London I United Kingdom 

� Rachel Clough 



� Martin Czerny 

Department for Cardiovascular Surgery | Inselspital | Bern | Switzerland 

� Alun H. Davies 

Department for Surgery and Cancer I Imperial College London I London I United Kingdom 

� Lena Deutsch 

Department for Vascular and Endovascular Surgery I Klinikum rechts der Isar der Technischen 

Universität München I Munich I Germany 

� Jean-Paul de Vries 

Department for Vascular Surgery I St. Antonius Hospital I Nieuwegein I The Netherlands 

� Konstantinos Donas 

Department for Vascular Surgery I Universitätsklinikum Munster I Munster I Germany 

� Arnd Dörfler 

Department for Neuroradiology I Universitätsklinikum Erlangen I Erlangen I Germany 

� Jonothan Earnshaw 

Department for Vascular Surgery I Gloucestershire Royal Hospital I Gloucestershire I United Kingdom 

19


FACULTY 

�� Ingo Flessenkämper 

Department for Vascular Medicine I HELIOS Klinikum Emil von Behring I Berlin I Germany 

� Annette Förschler 

Department for Neuroradiology I Klinikum rechts der Isar der Technischen Universität München I 

Munich I Germany 

� Christian Gasser 

Royal Institute of Technology I Stockholm I Sweden 

� Reza Ghotbi 

Department for Vascular Surgery I Klinikum München Pasing I Munich I Germany 

� Andreas Greiner 

Department for Vascular Surgery | Universitätsklinikum Aachen | Aachen | Germany 

� Jan Güra 

Philips GmbH | Hamburg | Germany 

� Martin Halle 

Department for Prevention, Rehabilitation and Sports Medicine I Klinikum rechts der Isar 

der Technischen Universität München I Munich I Germany 

� Alison Halliday 

Nuffield Department for Surgical Sciences I University of Oxford I Oxford I United Kingdom 

� Stéphan Haulon 

Department for Vascular Surgery I Hôpital Cardiologique I Lille I France 

� Bernhard Hemmer 

Department for Neurology I Klinikum rechts der Isar der Technischen Universität München I 


� Irene Hinterseher 

Department for General, Visceral, Vascular and Thoracic Surgery I Charité - Universitätsmedizin Berlin I 

Berlin I Germany 

� Michael Jacobs 

Department for Vascular Surgery I Universitätsklinikum Aachen I Aachen I Germany 

Department for Surgery I Maastricht University Medical Center I Maastricht I The Netherlands 

� Olav Jansen 

Department for Neuroradiology I Universitätsklinikum Schleswig-Holstein I Kiel I Germany 

� Johannes Kalder 

Department for Vascular Surgery I Universitätsklinikum Aachen I Aachen I Germany 

� Piotr Kasprzak 

Department for Vascular Surgery I UKR Universitätsklinikum Regensburg I Regensburg I Germany 

� Ali Khoynezhad 

Department for Thoracic Aortic Surgery I Cedars-Sinai Medical Center I Los Angeles I USA 

20


�� Thomas A. Koeppel 

Department for Surgery I Section of Vascular Surgery I Klinikum Großhadern der LMU I Munich I Germany 

� Tilo Kölbel 

Department for Vascular Medicine I Universitäres Herzzentrum I Hamburg I Germany 

� Eline Kooi 

Department for Radiology I University Medical Center I Maastricht I The Netherlands 

� Iina Laitinen 

Department for Nuclear Medicine I Klinikum rechts der Isar der Technischen Universität München I 


� Christos Liapis 

Department for Vascular Surgery I Attikon University Hospital I Athens I Greece 

� Thomas Liebig 

Department for Radiology I Universitätsklinik Köln I Cologne I Germany 

� Dieter Liepsch (emer.) 

Laboratory for Fluid Mechanics and Institute for Biotechnology I University of Applied Sciences I 


� Jan Lindeman 

Department for Surgery I Leiden University Medical Center I Leiden I The Netherlands 

� Sumaira Macdonald 

Consultant Vascular I Interventional Radiologist I Newcastle upon Tyne I United Kingdom 

� Andreas Maier 

Institute for Computational Mechanics I Technische Universität München I Munich I Germany 

� Armando Mansilha 

Department for Vascular Surgery I Sao Joao Hospital I Porto I Portugal 

� Andrew Newby 

Department for Vascular Cell Biology I University of Bristol I Bristol I United Kingdom 

� Christoph Nienaber 

Department for Cardiology I Universitätsklinikum Rostock I Rostock I Germany 

� Gerard Pasterkamp 

Laboratory of Experimental Cardiology I UMC Utrecht I Utrecht I The Netherlands 

� Thomas Pfefferkorn 

Department for Neurology I Klinikum Großhadern I Munich I Germany 

� Janet T. Powell 

Department for Surgery and Cancer I Imperial College London I London I United Kingdom 

� Vincent Riambau 

Vascular Surgery Division I Hospital Clinic at the University of Barcelona I Barcelona I Spain 

21


FACULTY 

�� Jean-Baptiste Ricco 

Department for Vascular Surgery I University Medical School of Poitiers I Poitiers I France 

� Peter Ringleb 

Department for Neurology I Universitätsklinikum Heidelberg I Heidelberg I Germany 

� Tobias Saam 

Department for Radiology I Ludwig-Maximilian Universität München I Munich I Germany 

� Hazim J. Safi 

Department for Cardiothoracic and Vascular Surgery I University of Texas Medical School at Houston I 

Houston I USA 

� Dirk Sander 

Department for Neurology I Benedictus-Krankenhaus Tutzing I Tutzing I Germany 

� Dirk Scheinert 

Department for Angiology and Cardiology I Park-Krankenhaus Leipzig I Leipzig I Germany 

� Hubert Schelzig 

Department for Vascular and Endovascular Surgery I Universitätsklinikum Dusseldorf I 

Dusseldorf I Germany 

� Felix Schlachetzki 

Department for Neurology | UKR Universitätsklinikum Regensburg | Regensburg | Germany 

� Jürg Schmidli 

Department for Cardiovascular Surgery I Inselspital I Bern I Switzerland 

� Carlo Setacci 

Department for Vascular and Endovascular Surgery I University of Siena I Siena I Italy 

� Malakh L. Shrestha 

Department for Cardiothoracic, Transplantation and Vascular Surgery I 

Medizinische Hochschule Hanover I Hanover I Germany 

� Mario Siebler 

Department for Neurology I MediClin Fachklinik Rhein/Ruhr I Essen I Germany 

� Henrik Sillesen 

Department for Vascular Surgery I Rigshospitalet I Copenhagen I Denmark 

� David Stevenson 

Vascutek Ltd. I Inchinnan, Renfrewshire I United Kingdom 

� Konrad Stock 

Department for Nephrology I Klinikum rechts der Isar der Technischen Universität München I 


� Peter Tassani-Prell 

Department for Anesthesiology I Deutsches Herzzentrum der Technischen Universität München I 


22


�� Peter Taylor 



� Matt Thompson 

Department for Surgery I St. George’s Healthcare Charity I London I United Kingdom 

� Giovanni Torsello 

Department for Vascular Surgery I Universitätsklinikum Munster I Munster I Germany 

� Thomas Umscheid 

Department for Vascular Surgery | HELIOS William Harvey Klinik | Bad Nauheim | Germany 

� Frank J. Veith 

Department for Surgery I NYU Langone Medical Center I New York I USA 

� Fabio Verzini 

Department for Vascular and Endovascular Surgery I Hospital S. Maria della Misericordia I Perugia I Italy 

� Edoardo Vicenzini 

Department for Neurology and Psychiatry I Sapienza University I Rome I Italy 

� Renu Virmani 

CV Path Institute I Gaithersburg I USA 

� Yskert von Kodolitsch 

Department for General and Interventional Cardiology I Universitäres Herzzentrum Hamburg I 

Hamburg I Germany 

� Wolfgang Wall 

Institute for Computational Mechanics I Technische Universität München I Munich I Germany 

� Christian Weber 

Institute for Cardiovascular Prevention I Ludwig-Maximilian Universität München I Munich I Germany 

� Christoph Weimar 

Department for Neurology I Universitätsklinikum Essen I Essen I Germany 

� Fritz Wodarg 

Department for Neuroradiology I Universitätsklinikum Schleswig-Holstein I Kiel I Germany 

� John Wolfe 

Department for Vascular Surgery I Emmanuel Kaye House I London I United Kingdom 

� Seppo Ylä-Herttuala 

Department for Biotechnology and Molecular Medicine I University of Kuopio I Kuopio I Finland 

� Clark Zeebregts 

Department for Surgery I University of Groningen I Groningen I The Netherlands 

23


Prof. Dr. med. Peter Berlit 

Essen | Germany 

Jonothan Earnshaw, MD, FRCS 

Gloucestershire | UK 

Prof. Hazim J. Safi, MD 

Houston | USA 

KEYNOTE AND SPECIAL LECTURES 

KEYNOTE LECTURE: Vasculitis of the extra- and intracranial 

arteries – etiology, stroke risk and treatments 

November 30th , 2012 | 11:00–11:20 

Peter Berlit studied medicine in Kiel and Marburg, Germany, followed by his practice 

of internal medicine and dermatology. Afterwards Peter Berlit became a resident in 

Neurology at the University Hospital in Heidelberg, Germany, leading to his habilitation 

as adjunct professor in 1989. His subsequent station was at the Department of 

Rheumatology at the University of California in San Diego, USA, as part of a visiting 

professorship. From 1985 to 1992 Peter Berlit assumed responsibility as Assistant 

Medical Director and temporarily Commissarial Manager at the Neurological Clinic 

in Mannheim, Germany. Since 1992 his work is appreciated as Director of the Neurological 

Institute with Clinical Neurophysiology at Alfried Krupp Hospital in Essen, 

Germany. Additionally, Peter Berlit acquired renown by publishing several textbooks 

for students and medical specialists. The most famous compendium “Memorix – 

Neurology” has been translated into 10 languages by now. Peter Berlit put his scientific 

focus on cerebrovascular diseases, neuroimmunology as well as autonomic disorders. 

KEYNOTE LECTURE: Triumphs and tribulations in a 

national AAA screening program 

November 30th , 2012 | 11:00–11:20 

As part of his qualification Jonothan Earnshaw rendered a great service to the Guy’s 

Hospital, London, in 1979. Before his current post as Consultant Vascular Surgeon at 

Gloucestershire Royal Hospital, UK, in 1991, he was Honorary Secretary of the 

Vascular Society of Great Britain and Ireland (VSGBI) from 2006 to 2010, previous 

Chair of the VSGBI’s Audit Committee and a member of the Society’s Professional 

Standards and Audit Committees. Moreover, Jonothan Earnshaw is the Chair elect of 

the Professional Standards Committee as well as chief editor of the British Journal 

of Surgery. Since 2009 he is Director of the NHS Abdominal Aortic Aneurysm Screening 

Programme in the UK, and advises the Department of Health on vascular issues. 

KEYNOTE LECTURE: Open surgery remains to be the 

golden standard for TAAA in surgically fit patients 

December 1st , 2012 | 11:00–11:20 

Hazim J. Safi is one of the leading specialists worldwide for open thoraco-abdominal 

aortic surgery. He is Professor and Chairman of the Department of Cardiothoracic 

and Vascular Surgery at the University of Texas Medical School in Houston and also 

author or co-author of more than 30 book chapters and over 200 scientific publications 

in medical journals. His profound clinical experience in treatment and management 

of complex aortic disease and his scientific work have helped to develop 

surgical techniques which greatly improve outcomes of complex aortic surgery. 

24

KEYNOTE AND SPECIAL LECTURES where doctors meet science 

SPECIAL LECTURE: Is there a need to centralize the vascular 

provision in dedicated high-volume centers? 

December 1st , 2012 | 12:35–13:00 

Matt Thompson is one of the most prominent Vascular Surgeons in Europe. He is Honorary 

Professor at the Imperial College of Vascular Surgery and the Head of the St. 

George’s Vascular Institute in London with widespread vascular research interests, 

though with emphasis on aortic aneurysm. He is author and co-author of a multitude 

of scientific publications and has a specialized clinical practice in the endovascular 

and open surgical treatment of complex aortic disease, which is internationally 

renowned. He is also advisor of the National Institute for Health and Clinical Excellence 

and of several strategic authorities on vascular services in the UK and is editor of 

three vascular journals. 

SPECIAL LECTURE: What besides patient benefit motivates 

vascular surgeons and vascular specialists? 

November 30th , 2012 | 12:35–13:00 

Frank J. Veith graduated from Cornell University Medical School before completing 

an internship at Columbia-Presbyterian Hospital in New York and residency training 

at Peter Bent Brigham Hospital and Harvard Medical School. In the 1970s and 80s 

he turned his attention toward vascular surgery with an emphasis on lower extremity 

revascularization procedures and the endovascular graft repair of abdominal aortic 

aneurysms. Frank J. Veith's group was the first to perform an endovascular aneurysm 

repair in the United States. Frank J. Veith held positions as Chief of Vascular Surgery 

and Chairman of Surgery at Montefiore Medical Center and Albert Einstein College 

of Medicine for many years. Moreover, he has held the William J. Von Liebig Chair in 

Vascular Surgery and has been the Vice Chairman of the Department of Surgery. 

In 1995 he was elected President of the Society for Vascular Surgery, and is past 

Chairman of The American Board of Vascular Surgery. 

KEYNOTE LECTURE: Similarity and differences between 

carotid, aortic and coronary atherosclerosis 

November 30th , 2012 | 14:30–14:50 

Renu Virmani is a Cardiovascular Pathologist as well as Chairman of the Department 

of Cardiovascular Pathology at the Armed Forces Institute of Pathology (AFIP) in Washington, 

D.C. Renu Virmani grew up in Delhi, India, where she specialized in pathology. 

She then moved to the US, married, and later started to work as researcher at 

the NIH (National Institutes of Health). After her licensure in 1975, Renu Virmani did 

her residency in pathology at George Washington University in D.C., and then returned 

to the NHLBI (National Heart, Lung and Blood Institute) as a fellowship holder until 

being hired as pathologist at the AFIP. She then accepted the position as Director of 

the Department of Autopsy at Vanderbilt University Medical Center in Nashville, TN, 

but returned to AFIP in 1984 as Chair of the Department of Cardiovascular Pathology. 

25 

Prof. Matt Thompson, MD 

London | UK 

Frank J. Veith, MD, FACS 

New York | USA 

Renu Virmani, MD, FACC 

Gaithersburg | USA


Friday, November 30 th , 2012 

11:00–13:00 and 13:30–15:30 

13:30–14:20 

LUNCHSESSION I – MEDTRONIC 

Optimized therapy of ruptured AAA 

Chair: T. A. Koeppel, Munich, Germany / H. Schelzig, Dusseldorf, Germany 

Management of the ruptured patient 


Technical aspects of EVAR for rAAA 

T. Umscheid, Bad Nauheim, Germany 

Optimized treatment of rAAA patients 


SYMPOSIA & WORKSHOPS 

SIMULATOR TRAINING FOR ENDOVASCULAR INTERVENTIONS – CORDIS 

This training offers a possibility to simulate interventions in the Carotis, Iliac, 

SFA and BTK arteries. There will be two Mentice simulators with designated 

Cordis employees to guide the participants through the endovascular materials 

and workflows. Depending on the participants’ skill level and the 

personal interest the 2h training can be used for interventions of different 

vessel segments. Participants should be at a beginner level. 

(Please register separately for this training via the attached registration 

form or the congress website www.munich-vascular-conference.com) 

LUNCHSESSION II – VASCUTEK 

Latest techniques in the treatment of aortic diseases 

Chair: J. Kalder, Aachen, Germany / M. L. Shrestha, Hanover, Germany 

Engineering and functional considerations of a ring stent design 

D. Stevenson, Renfrewshire, UK 

Fenestrated Anaconda – the range of possibilities 


Thoraflex Hybrid – new approach for 

thoracic aortic diseases 


26

SYMPOSIA & WORKSHOPS where doctors meet science 

16:00–16:45 

WORKSHOP – BOSTON SCIENTIFIC 


H. Berger, Munich, Germany 

(Please register seperately for this workshop via the attached registration 

form or the congress website www.munich-vascular-conference.com) 

Saturday, December 1 st , 2012 

13:30–14:20 

LUNCHSESSION III – PHILIPS 

Hybrid-OR – State of the art imaging in vascular surgery 

Hybrid-OR – Clinical experience 


Hybrid-OR – State of the art imaging 

in vascular surgery 

J. Güra, Hamburg, Germany 

LUNCHSESSION IV – W. L. GORE 

Clinical data and practical challenges in EVAR and TEVAR 

Chair: A. Assadian, Vienna, Austria 

Sharing experience: EVAR in more than 100 patients with the 

GORE®EXCLUDER® AAA Endoprosthesis 

R. Ghotbi, Munich, Germany 

Treatment of acute uncomplicated type B aortic 

dissection: 1 year results from the ADSORB study 

P. Taylor, London, UK 

27


GENERAL INFORMATION 

�� DATE AND VENUE 

Friday, November 30 th and Saturday, December 1 st , 2012 

Klinikum rechts der Isar (MRI) der Technischen Universität München (TUM) 

Ismaninger Strasse 22 | 81675 Munich | Germany 

�� CONGRESS ORGANISATION 

KelCon GmbH | Regina Uihlein 

Liebigstrasse 11 | 63500 Seligenstadt | Germany 

Phone: +49 (0)6182 94 666 32 | Fax: +49 (0)6182 94 666 44 

E-Mail: r.uihlein@kelcon.de | www.kelcon.de 

�� TRAVEL MANAGEMENT 

Our travel management is looking forward to assisting you with the 

organization and booking of your journey. 

Phone: +49 (0)6182 94 666 22 

E-Mail: firmendienst@kelcon.de 

�� CONGRESS SECRETARIAT 

Patricia von Reuss | Dr. Eva Knipfer | Heidi Söllner 

Department for Vascular and Endovascular Surgery 

Klinikum rechts der Isar der Technischen Universität München 

Ismaninger Strasse 22 | 81675 Munich | Germany 

Phone: +49 (0)89 41 40 21 67 | Fax: +49 (0)89 41 40 48 61 

E-Mail: gefaesschirurgie@lrz.tum.de 

�� CERTIFICATION 

An application has been made to the Bavarian Medical Association and the 

EACCME® (European Accreditation Council for Continuing Medical Education – 

Institution of the UEMS) for CME accreditation of this event. 

�� LANGUAGE 

The official congress language of this meeting is English. 

There will be no translations. 

28

GENERAL INFORMATION where doctors meet science 

�� REGISTRATION FEE 

Registration until Oct. 31 st from Nov. 1 st 

Physicians EUR 300.00 EUR 350.00 

Fellows, Nurses and MTs EUR 150.00 EUR 150.00 

Students free of charge 

Food and Beverages are included in the registration fee as well as 1 ticket for the 

Get-Together on Friday evening. 

For registration please use the website www.munich-vascular-conference.com 

or the attached registration form. 

� CANCELLATION POLICY 

Cancellations are required in writing and will be charged with the full registration fee. 

� GET-TOGETHER 

Friday, November 30 th , 2012, starting at 19:00 

8seasons Munich | Sonnenstrasse 26 | 80331 Munich | Germany 

With live music from the “Freddy Wonder Combo“ 

Dress Code: business casual 

Admission is included in the registration fee – we are looking forward to welcoming you. 

www.munich-vascular-conference.com 

29


SPONSORS 

GOLD EXHIBITORS 

SILVER 

BRONZE 

30 

� Abbott Vascular Deutschland GmbH 

� Aesculap AG 

� aimecs GmbH 

� Boston Scientific 

Medizintechnik GmbH 

� Bracco Imaging 

Deutschland GmbH 

� C. Nicolai GmbH 

� C. R. Bard GmbH 

� Cryolife Europa Ltd. 

� GVW – Gesellschaft für 

Versorgungskonzepte in der 

Wundbehandlung mbH 

� Johnson & Johnson Medical GmbH 

Cordis Medizinische Apparate GmbH 

ETHICON Products 

ETHICON Endo-Surgery 

� LeMaître Vascular GmbH 

� Lombard Medical Ltd. 

� MAQUET Vertrieb & 

Service Deutschland GmbH 

� Medi-Stim Deutschland GmbH 

� Nycomed GmbH 

� Pfizer Pharma GmbH 

� Sanofi-Aventis Deutschland GmbH 

� TriVascular Germany GmbH 

� UCB Pharma GmbH 

FURTHER SPONSORS 

� Aptus Endosystems Inc. 

� Bayer Vital GmbH 

� Philips GmbH

NOTES where doctors meet science 

31

Prinzregentenstrasse 

Nigerstrasse 

Parking 

access 

DIRECTIONS 

Ismaninger Strasse 

Trogerstrasse 

Main entrance 

Langerstrasse 

Parking 

access 

Einsteinstrasse 

Auditorium 

Max- 

Weber- 

Platz 

We highly recommend to use public transportation as the Klinikum rechts der Isar offers 

very limited parking possibilities. 

�� FROM MUNICH AIRPORT 

Please follow the signs “S-Bahn“ at the main terminal of the airport to the train station. 

We recommend using the line S8 towards Munich (München) to the station “Ostbahnhof”. 

Then change to the underground line U5 or U4 (U-Bahn) in direction to “Max-Weber- 

Platz” and get off at the station “Max-Weber-Platz”. Follow the signs “Einsteinstrasse” 

and “Einsteinstrasse/Klinikum rechts der Isar”. 

� FROM CENTRAL TRAIN STATION (HAUPTBAHNHOF) 

Follow the signs to the underground station and take line U4 /Arabellapark or U5/ 

Neuperlach. Get off the train at “Max-Weber-Platz” which is only four stations from the 

central train station. Follow the signs “Einsteinstrasse” and “Einsteinstrasse/ Klinikum 

rechts der Isar”.

program friday - Munich Vascular Conference

Create successful ePaper yourself

Delete template?

Save as template?